close

Beautiful Lips, Made Summer-Ready

Saypha® Lips Lidocaine is a cross-linked hyaluronic acid dermal filler specifically indicated for lip augmentation.





As we age, our lips lose volume due to declining collagen, elastin, and hyaluronic acid. This causes them to appear thinner and less defined and can also make the mouth’s corners turn downward, giving a tired or sad appearance.


Saypha® Lips Lidocaine expertly restores volume, enhancing your lips’ youthful appearance. Designed with more elastic than viscous properties, it effectively maintains its shape against the dynamic forces associated with lip movement.2 The incorporated lidocaine enhances patient comfort during treatment, providing a predictable and reliable lip fullness increase that’s clinically proven with long-lasting effectiveness and safety.1

Saypha lip fi ller is crafted to enhance lip volume and shape, ensuring a natural look. Its unique formulation sets it apart, providing an ideal solution for lip enhancement with minimal downtime and lasting results. At my clinic, we are committed to creating natural enhancements, and I am renowned for delivering natural-looking lip fi ller treatments. That’s why Saypha is my go-to choice for lip treatments.
Alexandra Mills INP PgDip
.


Limited Offer. Only available while stock lasts. We would like to thank you for your order and trust in Croma. T&C‘s Apply. Whilst stocks last. 8 masks per pack.

1. Müller et al. (2024) - Aesth Surg J. 2. Czumbel et al (2021) - Front Surg. 3. Instruction of Use a % of sum of “somewhat satisfied” + “definitely satisfied” for “suit face” (86.4%) and “smile” (83.6%), based on FACE-Q® questionnaire subject satisfaction with lips (Full Analysis Set) at month 12. FACE Q® - U.S. registered trademark of Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. The healthcare professionals confirms having informed the consumer of a likely risk associated with the use of the device in line with its intended use. For risk and adverse events associated with the use of the device consult the instruction of use. CE 0123

Concentration HA: 2.3 % | Crosslinking agent: BDDE (concentration s2ppm) | Crosslinking degree: 0.5 - 1.0 % Particle size: ~ 316 µm | Injection depth: Submucosa | Needle: 27G x ½ „ thin wall Terumo™ needle (CE 0197) Packaging unit: 1 box of 1 mL syringe co-packed with 2 needles | Indication: Lip augmentation3



Recommended
© Wigmore Medical is a registered pharmacy: no. 9012271